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INTRODUCTION
Epidermolysis bullosa simplex (EBS) is a genetic disease with predominantly autosomal dominant inheritance, characterized by fragility of the skin caused by minor trauma. [1] Severity of disease in the four clinical subtypes of EBS ranges from relatively mild blistering of the hands and feet in the Weber Cockayne (EBS-WC) type to more generalized blistering in the Koebner's type (EBS-K), EBS with mottled pigmentation (EBS-MP), and the Dowling Meara variety (EBS-DM) which can even be fatal. [2] All four forms of EBS are caused by mutation in either the Keratin 5 gene (KRT5, gi 27503816) or the Keratin 14 gene (KRT14 gi 27769301).
[3] KRT5 and KRT14 have 590 and 472 amino acids respectively and they form obligatory heterodimers, which self-assemble into 10 nm intermediate filaments (IF) . Like all IF proteins, they have a central α-helical rod domain, flanked by nonhelical head and tail domains. The helix initiation region, linker region and the helix termination region are the mutational hot spots. [4] Hence the clinical subtype and the severity could depend on various factors like the location of mutation, alteration in the type of amino acid, and the type of keratin involved.
Neural network is a statistical analysis tool, i.e. it lets us build behavior models starting from a collection of examples (defined by a series of numeric or textual descriptive variables) of this behavior. [5] The neural net, ignorant at the start, through a learning process, becomes a model of the dependencies between the descriptive variables and the behavior to be explained. The model is automatically and straightforwardly built from the data with no intervention needed at any stage. However, the success of neural networks largely depends on their architecture, their algorithm, and the choice of features used in training. Unfortunately, determining the architecture of a neural network is a trial-and-error process.
Several mutations have been identified in EBS following sequence analysis of 28 cases. [6] We performed neural network analysis on this data to find hidden patterns and an attempt was made to predict the phenotypic presentation based on the mutation.
METHODS
Twenty eight Cases of EBS in which sequencing had been performed to identify the position and type of mutation were collected by a literature search. A numeric code was assigned to the type of mutation (Table 1) .
A neural network software called Neunet Pro marketed by Cormac Technologies Inc, Canada was used for the analysis. A trial version of the software is available for free download from http://www.cormactech.com/ neunet/index.htm The variables included for 'training' are explained in Table 2 . Shuffling of data rows was done prior to training. Finally the 'SFAM' method (Simplified Fuzzy Adaptive Resonance Theory Map) of the software was used to predict the 'disease' variable.
The first 24 rows were selected as the 'training set'. The 'testing set' comprised the last 9 rows which included 4 rows that were not exposed during training.
RESULTS
The details of the 'training set' and 'testing set' of patients are tabulated in Table 3 .
DISCUSSION
Transmission electron microscope examination of a skin biopsy or immunofluorescent antibody/antigen mapping is the sine qua non for the diagnosis of EBS at present. [8] The severity of the disease ranges from An acidic or basic amino acid substituted by a polar amino acid or vice-versa 3.
A polar amino acid substituted by a non-polar amino acid or vice-versa 4.
An acidic or basic amino acid substituted by a non-polar amino acid or vice-versa 5.
An acidic amino acid substituted by a basic amino acid or vice-versa 6.
Deletion of an amino acid 7.
Mutation leading to abnormal termination of the chain Note: EBS-MP was not included in the study because it is always associated with a single type of mutation (KRT5 P24L) [7] Neural network algorithm has been successfully employed for predicting prostatic cancer [9] and for other applications in dermatology like skin capillary network recognition.
[10] However in our case, there is only a limited amount of data available and the accuracy rate of the prediction is only 78%. Hence the utility of this prediction algorithm is questionable. However, this highlights the worth of 'neural networks' as a statistical analysis tool that can be effectively used to find hidden patterns in large databases related to dermatology.
